Evidence map›Paper›PMID 37980357›Full record

ArticleNature communications2023

The homeodomain transcriptional regulator DVE-1 directs a program for synapse elimination during circuit remodeling.

Kellianne D Alexander, Shankar Ramachandran, Kasturi Biswas, Christopher M Lambert, Julia Russell, Devyn B Oliver, William Armstrong, Monika Rettler, Samuel Liu, Maria Doitsidou and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Kellianne D AlexanderDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-4572-2600
Shankar RamachandranDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Kasturi BiswasDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0001-7243-1422
Christopher M LambertDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Julia RussellDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Devyn B OliverDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0001-5209-0536
William ArmstrongDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Monika RettlerDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Samuel LiuDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID 0000-0002-7082-6823
Maria DoitsidouCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, Scotland.ORCID 0000-0002-2358-9810
Claire BénardDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Amy K WalkerProgram in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Michael M FrancisDepartment of Neurobiology, University of Massachusetts Chan Medical School, Worcester, MA, USA. Michael.Francis@umassmed.edu.ORCID 0000-0002-8076-6668
University of Massachusetts Chan Medical School · USUniversité du Québec à Montréal · CAUniversity of Edinburgh · GB

Funding

Molecular Analysis of Neural Circuit Excitation and InhibitionR01NS064263 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FRANCIS, MICHAEL M · 2009 to 2025
$5.5M
Role of methylation-dependent pathways in aging and stressR01AG053355 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Amy Karol Walker · 2017 to 2026
$4.5M
Dual transcriptional programs coordinate lipogenic and membrane stress responsive programs in C. elegans - SupplementR01AG068670 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WALKER, AMY KAROL · 2021 to 2025
$2.1M
NIA NIH HHS R01 AG053355NIA NIH HHS R01 AG068670NINDS NIH HHS F31 NS113476NINDS NIH HHS R01 NS064263
6 · The paper itself

Abstract

The elimination of synapses during circuit remodeling is critical for brain maturation; however, the molecular mechanisms directing synapse elimination and its timing remain elusive. We show that the transcriptional regulator DVE-1, which shares homology with special AT-rich sequence-binding (SATB) family members previously implicated in human neurodevelopmental disorders, directs the elimination of juvenile synaptic inputs onto remodeling C. elegans GABAergic neurons. Juvenile acetylcholine receptor clusters and apposing presynaptic sites are eliminated during the maturation of wild-type GABAergic neurons but persist into adulthood in dve-1 mutants, producing heightened motor connectivity. DVE-1 localization to GABAergic nuclei is required for synapse elimination, consistent with DVE-1 regulation of transcription. Pathway analysis of putative DVE-1 target genes, proteasome inhibitor, and genetic experiments implicate the ubiquitin-proteasome system in synapse elimination. Together, our findings define a previously unappreciated role for a SATB family member in directing synapse elimination during circuit remodeling, likely through transcriptional regulation of protein degradation processes.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsAnimalsGABAergic NeuronsHumansReceptors, CholinergicSynapsesCaenorhabditis elegans ProteinsReceptors, Cholinergic

Identifiers

PMID37980357
PMCPMC10657367
OpenAlexW4388789393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.